Direct comparison
Cell Dissociation Reagents Compared
Compare trypsin, recombinant (TrypLE/Accutase-type), collagenase/dispase, and non-enzymatic dissociation reagents on mechanism, epitope impact, and sourcing.
Ask about Cell Dissociation Reagents Compared
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Porcine trypsin (crude/purified), Recombinant, animal-origin-free (TrypLE-/Accutase-type), Collagenase / dispase blends, Non-enzymatic (EDTA/chelation) compare side by side?
The table below compares Porcine trypsin (crude/purified), Recombinant, animal-origin-free (TrypLE-/Accutase-type), Collagenase / dispase blends, Non-enzymatic (EDTA/chelation) across 9 procurement-relevant dimensions, from mechanism through when to avoid.
Side-by-side comparison
| Dimension | Porcine trypsin (crude/purified) | Recombinant, animal-origin-free (TrypLE-/Accutase-type) | Collagenase / dispase blends | Non-enzymatic (EDTA/chelation) |
|---|---|---|---|---|
| Mechanism | Serine protease cleaves cell-surface and matrix proteins non-specifically to break cell-substrate and cell-cell adhesion | Recombinant serine protease (or protease blend) engineered/produced for trypsin-like activity without animal sourcing | Cleaves collagen and other ECM proteins directly; often blended with a neutral protease (dispase) to also loosen cell-cell junctions | Chelates divalent cations (Ca2+/Mg2+) that cadherins and other adhesion proteins require, weakening junctions without proteolysis |
| Typical use case | Routine passaging of robust adherent lines (e.g., many immortalized monolayer cultures) where surface-epitope integrity is not critical | Flow cytometry, cell sorting, single-cell workflows, and any downstream step where surface-marker or receptor integrity matters | Primary tissue dissociation, organoids, tumor or ECM-rich samples where trypsin alone under-digests the matrix | Gentle passaging of loosely adherent or fragile lines, or short-term detachment immediately before an assay sensitive to any proteolysis |
| Effect on surface epitopes/receptors | Can cleave surface receptors and some antibody epitopes — a known confound in downstream flow cytometry or receptor-binding assays | Formulated to be gentler on common surface markers than crude trypsin, though not epitope-neutral — verify against the specific marker panel | Targets matrix rather than surface protein directly, but dispase components can still affect some receptors | Minimal proteolytic epitope disruption — the reason it is preferred immediately before antibody-based assays where trypsin would confound results |
| Animal-origin-free availability | Porcine-derived by default; animal-origin-free versions exist but are a separate SKU, not the standard product | Animal-origin-free by design — this is the primary reason the category exists for cell-therapy-adjacent and xeno-free workflows | Historically bacterial-fermentation-derived (Clostridium) but formulation/purification can still carry animal-derived components — confirm sourcing per lot | Chelator-based formulations are typically animal-component-free, but confirm the full buffer/media base is also xeno-free if that matters for the application |
| Grade tiers available | Research-grade is standard; USP <1043>-referenced GMP grades exist for cell/gene therapy manufacturing but at a materially higher price point | Available across research-grade through GMP grades manufactured under quality systems referencing USP <1043> ancillary-material guidance | Predominantly research-grade; GMP-grade collagenase/dispase blends are a narrower, higher-cost market than GMP trypsin alternatives | Predominantly research-grade; less commonly manufactured to GMP ancillary-material specifications |
| Documentation to request from a supplier | Certificate of Analysis (activity units, sterility), lot-to-lot activity consistency data; endotoxin/mycoplasma testing if used near cell-therapy work | Certificate of Analysis, animal-origin-free/xeno-free declaration, endotoxin and mycoplasma test results, and — for GMP SKUs — a Drug Master File reference or equivalent regulatory support file | Certificate of Analysis with specific activity (units/mg), source organism/strain, endotoxin level, and lot-specific enzyme-ratio data (collagenase:dispase varies lot to lot and affects digestion consistency) | Certificate of Analysis (sterility, endotoxin if relevant), formulation/buffer composition, and stability data |
| Storage & shelf-life considerations | Typically frozen aliquots or refrigerated ready-to-use solutions; activity degrades with freeze-thaw cycling — single-use aliquoting is standard practice | Similar cold-chain handling to trypsin; check manufacturer freeze-thaw stability data before adopting a multi-use aliquot policy | More freeze-thaw-sensitive than trypsin in practice — lot-specific activity loss is a common cause of inconsistent primary-tissue digestion | Generally more stable at 4C with a longer working shelf life since there is no enzyme activity to preserve |
| Relative cost tier | Lowest cost per use for research-grade material | Moderate to high — premium over crude trypsin for animal-origin-free sourcing and documentation | Moderate to high, with meaningful lot-to-lot activity variability driving effective cost through repeat/failed digestions | Moderate — comparable to or above standard trypsin depending on formulation |
| When to avoid | Avoid where surface-marker integrity is assay-critical, or where an animal-origin-free supply chain is a stated requirement | Rarely a wrong choice on biology grounds; the main constraint is budget and, for GMP tiers, lead time | Avoid for routine monolayer passaging where a simpler, cheaper reagent achieves the same result | Avoid for tightly-junctioned or ECM-dense tissue — it will under-dissociate and yield poor single-cell suspensions |
Common questions
Common questions about Porcine trypsin (crude/purified) vs Recombinant, animal-origin-free (TrypLE-/Accutase-type) vs Collagenase / dispase blends vs Non-enzymatic (EDTA/chelation)
What is the actual difference between trypsin and Accutase-type recombinant reagents?
+
Both are proteases that break down cell-surface and matrix adhesion proteins to release cells from a substrate or from each other. The practical differences are sourcing (porcine-derived trypsin vs. recombinant, animal-origin-free production) and gentleness — recombinant, animal-origin-free formulations are generally marketed and used where surface-epitope preservation for downstream flow cytometry or antibody-based assays matters more than raw cost.
Do I need animal-origin-free (AOF) dissociation reagents for my work?
+
It depends on downstream use, not on general caution. Cell-therapy and other regulated cell/gene-therapy manufacturing contexts typically require ancillary materials — including dissociation enzymes — to be sourced and documented in line with GMP quality-system expectations, for which USP General Chapter <1043> on Ancillary Materials for Cell, Gene, and Tissue-Engineered Products is a widely referenced framework. Routine research-only workflows generally do not require AOF sourcing unless a specific protocol, funder, or downstream regulatory pathway calls for it — check your protocol and institutional biosafety/quality requirements before defaulting to the more expensive tier.
What should I ask a supplier for before adding a dissociation reagent to a standing order?
+
At minimum: a Certificate of Analysis for the specific lot (enzyme activity or specific activity, sterility, endotoxin level where relevant), a statement of animal-origin status, and evidence of lot-to-lot consistency testing — particularly for collagenase/dispase blends, where enzyme-ratio variability between lots is a well-known cause of inconsistent tissue digestion. For GMP-grade material intended for cell/gene therapy manufacturing, also request the regulatory support documentation (e.g., a Drug Master File reference) the manufacturer maintains for that product.
Why does collagenase/dispase lot variability matter for procurement?
+
Collagenase is typically produced by bacterial fermentation and purified as a blend of several proteolytic activities alongside dispase; the ratio of these activities can shift between production lots even within the same catalog number. For primary-tissue or organoid work where digestion consistency drives yield and viability, it is standard practice to request lot-specific activity data and, where budget allows, to qualify and reserve a preferred lot rather than accepting whatever ships next.
Can dissociation reagents be substituted for one another without changing the protocol?
+
Not safely. Switching from trypsin to a non-enzymatic chelator, or from a generic recombinant enzyme to a different formulation, changes dissociation kinetics and can change cell viability, yield, and surface-marker integrity. Treat a reagent-class change as a protocol change requiring its own qualification run, not a like-for-like vendor swap.
Going deeper
